BiotechTube
Home/Actinium Pharmaceuticals/Adeela Kamal
AK

Adeela Kamal

Executive Vice President, Head of Research and Development

Actinium Pharmaceuticals

Therapeutic Areas

OncologyHematologic Oncology

Actinium Pharmaceuticals Pipeline

DrugIndicationPhase
Iomab-B (apamistamab-I-131)Relapsed/Refractory AML prior to Bone Marrow TransplantPhase 3
Actimab-A (lintuzumab-Ac-225)Relapsed/Refractory AMLPhase 2/3
ATNM-400Metastatic Castration-Resistant Prostate Cancer (mCRPC)Preclinical
Iomab-ACTConditioning for Cell & Gene TherapiesResearch

Leadership Team at Actinium Pharmaceuticals

SS
Sandesh Seth
Chief Executive Officer and Chairman of the Board
JG
Julie Gibson
Vice President, Portfolio and Clinical Operations
RC
Ryan Chu
Vice President, Finance and Investor Relations
PD
Paul Diamond
Vice President, Legal and Intellectual Property Counsel
CD
C. David Nicholson
Lead Independent Director
AS
Ajit Shetty
Director
View full Actinium Pharmaceuticals profile